01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

01Overview 02Follow the Money 03Daily Brief 04Live 05Congress 06Corporate Insiders 07Government Money 08Political Influence 09Institutions 10Washington Network 11Follow the Power 12Disclosure Clock 13AI Investigator 14Watchlist

Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Overview Follow the Money Daily Brief Live Congress Corporate Insiders Government Money Political Influence Institutions Washington Network Follow the Power Disclosure Clock AI Investigator Watchlist Convergence INSIDER Alpha Signal ledger Historical Replay Robinhood Chain Proof Trading Token Pro Account Methodology Match review Launch readiness

Data sources

SEC FORM 42h ago

HOUSE PTR2h ago

SEC 13F2h ago

ROBINHOOD CHAIN2h ago

Public company

OMEROMEROS CORP

CIK 0001285819

EDGAR filings Open in network

Disclosed transactions0

Buys / sells0 / 0

Max Insider Score—

Connections4with evidence

OMER · disclosed activity on price

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

In industryevidence
Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 4, 2026
← Lobbied forevidence
AQUIA GROUP, LLCLDA 1TY 2026 first quarter · issues not listed · Aug 26, 2026
← Lobbied forevidence
THE PETRIZZO GROUP, INC.LDA RA 2026 third quarter · Health issues, MED · Aug 26, 2026
← Lobbied forevidence
THE NICKLES GROUP, LLCLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026

Lobbying

$0 reported · de-duplicated

2026 Q3 $0 via firms2026 Q2 $0 via firms2026 Q1 $0 via firms

THE NICKLES GROUP, LLC—2026 Q2 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
AQUIA GROUP, LLC—2026 Q1 · posted Aug 26, 2026 ·
THE NICKLES GROUP, LLC—2026 Q1 · posted Aug 26, 2026 · Medicare/Medicaid, Health issues
THE PETRIZZO GROUP, INC.—2026 Q3 · posted Aug 26, 2026 · Health issues, MED

Connected PAC contributions

FEC · direct to members

No contributions from a PAC connected to this company.